SGMT — Sagimet Biosciences Inc. Series A Common Stock · $403.2M cap

Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.

Use this SGMT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SGMT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SGMT SEC filings page. Lician reads the product cache first so this HTML stays unique to Sagimet Biosciences Inc. Series A Common Stock even when a live quote feed is slow.

Sagimet Biosciences Inc. Series A Common Stock latest statements (FY2025)

Latest cached year on this hub. Full SGMT income, balance, and cash tables.

  • Revenue$0
  • Net Income-$51.0M
  • Total Assets$116.5M
  • Total Debt$0
  • Free Cash Flow$0

SGMT recent filings